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Background
Evidence suggests that CD8 T cells are important to the
control of HIV replication in elite controllers. However,
the mechanism behind the enhanced suppressive capacity
of CD8 T cells in these subjects remains unclear.
Methods
We have recently discovered the novel ability of human
CD8 T cells to rapidly upregulate perforin following anti-
gen-specific stimulation. Using polychromatic flow
cytometry and standard intracellular cytokine staining
assays, we measured perforin expression, cytokine pro-
duction, and degranulation by CD8 T cells following stim-
ulation using overlapping peptide pools encompassing
the entire HIV proteome. We studied several HIV-infected
groups that differentially control viral replication off ther-
apy: elite controllers (n = 34), viremic controllers (n = 29),
chronic progressors (n = 24), and viremic nonprogressors
(n = 6).
Results
We observe that on average 40% of the total CD8 T cell
response in elite controllers is perforin-positive following
HIV-specific stimulation compared to 20% in the other
cohorts. However, the proportion of the HIV-specific CD8
T cell response that produces IFN-gamma does not vary
widely between the groups. Elite controllers have a signif-
icantly larger proportion of responding CD8 T cells that
degranulate yet remain perforin-positive following 6
hours of stimulation, suggesting that CD8 T cells in these
individuals have an increased capacity to upregulate new
perforin production. The cells that express perforin, which
are enriched in elite controllers, display almost entirely an
effector phenotype (CD27negCD45ROnegCD57+/-).
Overall, there is a strong negative correlation (p < 0.0001)
between HIV-specific perforin expression and viral load.
This finding is not simply the result of the low viral load
in elite controllers as HIV-specific perforin expression is
not restored in HAART-suppressed patients (n = 12).
Conclusion
The rapid perforin upregulation displayed by CD8 T cells
in elite controllers may contribute to the superior control
of HIV replication in these subjects. Continuous perforin
expression following initial antigen encounter allows for
the sustained cytotoxic potential of anti-viral CD8 T cells.
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